Influence of ORF2 on host cell tropism of feline immunodeficiency virus

Virology

Volumn 215, Issue 1, 1996, Pages 10-16

  Waters, A K ^a   De Parseval, A P ^a   Lerner, D L ^a   Neil, J C ^b   Thompson, F J ^b   Elder, J H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; GENE EXPRESSION REGULATION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS VIRULENCE;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; LENTIVIRUS;

EID: 0030065526     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0002     Document Type: Article

References (31)

1. Carruth, L. M., Hardwick, J. M., Morse, B. A., and Clements, J. E. (1994). Visna virus tat protein: A potent transcription factor with both activator and suppressor domains. J. Virol. 68(10), 6137-6146.
2. Chen, C., and Okayama, H. (1987). High efficiency transformation of mammalian cells by plasmid DNA Mol. Cell. Biol. 7, 2745-2752.
3. Clements, J. E., and Payne, S. L. (1994). Molecular basis of the pathobiology of lentiviruses. Virus Res. 32, 97-109.
4. Cress, W. D., and Triezenberg, S. T. (1991). Critical structural elements of the VP16 transcriptional activation domain. Science 251, 87-90.
5. Davis, J. L., and Clements, J. E. (1989). Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc. Natl. Acad. Sci. USA 86, 414-418.
6. Elder, J. H., and Phillips, T. R. (1994). Molecular properties of feline immunodeficiency virus (FIV). Infect. Agents Dis. 2, 361-374.
7. Fischinger, P. J., Peebles, P. T., Nomura, S., and Haapala, D. K. (1973). Isolation of RD-144-like oncornavirus from a cat cell line. J. Virol. 11, 978-985.
8. Gdovin, S. L., and Clements, J. E. (1992). Molecular mechanisms of visna virus tat: Identification of the targets for transcriptional activation and evidence for a post-transcriptional effect. Virology 188, 438-450.
9. Gorman, C. M., Moffast, L. F., and Howard, B. H. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
10. Gourdou, I., Mazarin, V., Querat, G., Sauze, N., and Vigne, R. (1989). The open reading frame of the visna virus genome is a trans-activating gene. Virology 171, 170-178.
11. Hall, C. V., Jacob, P. E., Ringold, G. M., and Lee, F. (1983). Expression and regulation of Escherischia coli lacZ gene fusions in mammalian cells. J. Mol. Appl. Genet. 2, 101-109.
12. Hess, J. L., Clements, J. E., and Narayan, O. (1985). cis- and frans-acting transcriptional regulation of visna virus. Science 229, 482-485.
13. Hess, J. L., Small, J. A., and Clements, J. E. (1989). Sequences in the visna viral long terminal repeat that control transcriptional activity and respond to viral trans-activation: Involvement of ap-1 sites in basal activity and trans-activation. J. Virol. 63(7), 3001-3015.
14. Kalinski, H., Mashiah, P., Rotem, D., Orzech, Y., Sherman, L., Miki, T., Yaniv, A., Gazit, A., and Tronicki, S. R. (1994). Characterization of cDNAs species encoding the tat protein of caprine arthritis and encephalitis virus. Virology 204, 828-834.
15. Lerner, D. L., Wagaman, P. C., Phillips, T. R., Prospero-Garcia, O., Henriksen, S. J., Fox, H. S., Boom, F. E., and Elder, J. H. (1995). Increased mutation frequency of FIV lacking functional deoxyuridine triphosphatase. Proc. Natl. Acad. Sci. USA 92, 7480-7484.
16. Miyazawa, T., Kohmoto, M., Kawaguchi, Y., Tomonaga, K., Toyosaki, T., Ikuta, K., Adachi, A., and Mikami, T. (1993). The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes. J. Gen. Virol. 74, 1573-1580.
17. Neuveut, C., Vigne, R., Clements, J. E., and Sire, J. (1993). The visna transcriptional activator tat: Effects on the viral LTR and on cellular genes. Virology 197, 236-344.
18. Olmsted, R. A., Barnes, A. K., Yamamoto, J. K., Hirsch, V. M., Purcell, R. H.,and Johnson, P. R. (1989a). Molecular cloning of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86, 2448-2452.
19. Olmsted, R. A., Hirsch, V. M., Purcell, R. H., and Johnson, P. R. (1989b). Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses. Proc. Natl. Acad. Sci. USA 86, 8088-8092.
20. Pedersen, N. C., Ho, E. W., Brown, M. L., and Yamamoto, J. K. (1987). Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 790-793.
21. Phillips, T. R., Lamont, C., Konings, D. A., Shacklett, B. L., Hamson, C. A., Luciw, P. A., and Elder, J. H. (1992). Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66, 5464-5471.
22. Phillips, T. R., Talbott, R. L., Lamont, C., Muir, S., Lovelace, K., and Elder, J. H. (1990). Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64, 4605-4613.
23. Sarkar, G., and Sommer, S. S. (1990). The "Megaprimer" method of site-directed mutagenesis. BioTechniques 8, 404-407.
24. Sparger, E. E., Shacklett, B. L., Renshaw-Gegg, L., Barry, P. A., Pedersen, N. C., Elder, J. H., and Luciw, P. A. (1992). Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187, 165-177.
25. Sparger, E. E., Beebe, A. M., Dua, N., Himathongkam, S., Elder, J. H., Torten, M., and Higgins, J. (1994). Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. Virology 205, 546-553.
26. Talbott, R. L., Sparger, E. E., Lovelace, K. M., Fitch, W. M., Pedersen, N. C., Luciw, P. A., and Elder, J. H. (1989). Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86, 5743-5747.
27. Taylor, J. P., Pomerantz, R. J., Raj, G. V., Kashanchi, F., Brady, J. N., Amini, S., and Khalili, K. (1994). Central nervous system-derived cells express a κB-binding activity that enhances human immunodeficiency virus type 1 transcription in vivo and facilitates TAR-independent transactivation by Tat. J. Virol. 68, 3971-3981.
28. Thompson, F. J., Elder, J., and Neil, J. C. (1994). cis- and trans-regulation of feline immunodeficiency virus: Identification of functional binding sites in the long terminal repeat. J. Gen. Virol. 75, 545-554.
29. Tomonaga, K., Miyazawa, T., Sakuragi, J.-I., Mori, T., Adachi, A., and Mikami, T. (1993a). The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes. J. Virol. 67(10), 5889-5895.
30. Tomonaga, K., Shin, Y.-S., Fukasawa, M., Miyazawa, T., Adachi, A., and Mikami, T. (1993b). Feline immunodeficiency virus gene expression: Analysis of the RNA splicing pattern and the monocistronic rev mRNA. J. Gen. Virol. 74(pt. II), 2409-2417.
31. Tong-Starksen, S., and Peterlin, B. M. (1990). Mechanisms of retroviral transcriptional activation. Semin. Virol. 1, 215-227.